| Reaction Details |
|---|
 | Report a problem with these data |
| Target | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] |
|---|
| Ligand | BDBM50607641 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2263018 (CHEMBL5218029) |
|---|
| IC50 | 1.6±n/a nM |
|---|
| Citation |  Hu, B; Toda, K; Wang, X; Antczak, MI; Smith, J; Geboers, S; Nishikawa, G; Li, H; Dawson, D; Fink, S; Desai, AB; Williams, NS; Markowitz, SD; Ready, JM Orally Bioavailable Quinoxaline Inhibitors of 15-Prostaglandin Dehydrogenase (15-PGDH) Promote Tissue Repair and Regeneration. J Med Chem65:15327-15343 (2022) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] |
|---|
| Name: | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] |
|---|
| Synonyms: | 15-PGDH | 15-hydroxyprostaglandin dehydrogenase [NAD+] | HPGD | PGDH1 | PGDH_HUMAN | Prostaglandin dehydrogenase 1 (15-PGDH) | SDR36C1 |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 28974.46 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P15428 |
|---|
| Residue: | 266 |
|---|
| Sequence: | MHVNGKVALVTGAAQGIGRAFAEALLLKGAKVALVDWNLEAGVQCKAALDEQFEPQKTLF
IQCDVADQQQLRDTFRKVVDHFGRLDILVNNAGVNNEKNWEKTLQINLVSVISGTYLGLD
YMSKQNGGEGGIIINMSSLAGLMPVAQQPVYCASKHGIVGFTRSAALAANLMNSGVRLNA
ICPGFVNTAILESIEKEENMGQYIEYKDHIKDMIKYYGILDPPLIANGLITLIEDDALNG
AIMKITTSKGIHFQDYDTTPFQAKTQ
|
|
|
|---|
| BDBM50607641 |
|---|
| n/a |
|---|
| Name | BDBM50607641 |
|---|
| Synonyms: | CHEMBL5220078 | US11718589, Compound 59b |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C18H18N6O |
|---|
| Mol. Mass. | 334.3751 |
|---|
| SMILES | Nc1ncc(cn1)-c1cnc2ccc(cc2n1)C(=O)N1CCCCC1 |
|---|
| Structure | 
|
|---|
Search and Browse
